Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

InspireMD, Inc.

NSPR · Nasdaq · CIK 0001433607 · Healthcare · Medical Devices

INSIDER SIGNAL

65.4 / 100

4 buyers · 13 purchase transaction lines · $454.1K gross purchase

WHY THIS SIGNAL?

Buyer breadthStrong
Purchase sizeModerate
RoleModerate
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+28.0 / 35
Purchase size+14.0 / 25
Role+13.0 / 20
Recency+0.9 / 10
Conviction+9.5 / 10

What is holding the score back?

  • ⚠ Role scores low · most senior buyer: CEO and President (CEO, chair and 10% owners score lowest)
  • ⚠ Purchase activity is becoming less recent
  • ✓ Cluster breadth is broad · 4+ insiders

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Purchase breadth & concentration

QUALIFYING BUYERS4
PURCHASE CONCENTRATION48%Largest buyer: Stuka Paul · $220.0K
CLUSTER BUYING · 15D4 insidersPeak activity: 2026-05-06–2026-05-14

Roles in the peak window: CEO and President, Director. Concentration uses priced qualifying P lines only and does not change the saved score.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Stuka PaulDirector
●●●●●●●●●
Ward Scott R.Director
●●
Gleason Shane ThomasChief Commercial Officer
▼
Slosman MarvinCEO and President
●
ROUBIN GARY SDirector
●
● Purchase▼ Sale○ Other

—

SIGNAL HISTORY

65.4 / 100

Latest recorded score

→ +0.0 ptsversus the previous recorded snapshot
  1. 65.6
  2. 65.5
  3. 65.5
  4. 65.4
  5. 65.4

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

18Purchases
11Sales
11Other Form 4 lines
26SEC filings · 365 days
BUYING13 qualifying P line(s) · 180 days
SELLING1 sale line(s) · context only
OTHER0 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-33.3%
3M
-27.8%
6M
-59.7%
12M
-78.7%

Volatility & liquidity

Volatility
60.4%
Beta
—
Avg daily value
USD 42,397

Valuation

Market cap
USD 24.2M
P/E
—

Fundamentals

Profit margin
-543.4%
ROE
-88.4%
Industry
Medical Devices

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-14 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
22,466
Previous report
25,364
Avg daily volume
70,548
Days to cover
≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-05-27Stuka PaulPurchase (P)Common Stock20,000USD 0.88USD 17,600SEC filing ↗
2026-05-14Stuka PaulPurchase (P)Common Stock5,000USD 1.15USD 5,750SEC filing ↗
2026-05-13Stuka PaulPurchase (P)Common Stock10,000USD 1.16USD 11,600SEC filing ↗
2026-05-12Slosman MarvinPurchase (P)Common Stock21,000USD 1.20USD 25,200SEC filing ↗
2026-05-11Stuka PaulPurchase (P)Common Stock10,000USD 1.19USD 11,900SEC filing ↗
2026-05-11Stuka PaulPurchase (P)Common Stock10,000USD 1.19USD 11,900SEC filing ↗
2026-05-08Stuka PaulPurchase (P)Common Stock65,626USD 1.16USD 76,126SEC filing ↗
2026-05-08Stuka PaulPurchase (P)Common Stock65,626USD 1.16USD 76,126SEC filing ↗
2026-05-07Ward Scott R.Purchase (P)Common Stock73,255USD 1.15USD 84,243SEC filing ↗
2026-05-07Stuka PaulPurchase (P)Common Stock6,378USD 1.15USD 7,335SEC filing ↗
2026-05-07ROUBIN GARY SPurchase (P)Common Stock90,000USD 1.18USD 106,200SEC filing ↗
2026-05-06Ward Scott R.Purchase (P)Common Stock15,995USD 1.15USD 18,394SEC filing ↗
2026-05-06Stuka PaulPurchase (P)Common Stock1,517USD 1.12USD 1,699SEC filing ↗
2025-12-09Stuka PaulPurchase (P)Common Stock2,710USD 1.81USD 4,905SEC filing ↗
2025-12-09Stuka PaulPurchase (P)Common Stock5,073USD 1.81USD 9,182SEC filing ↗

Form 4 evidence

40 transaction lines in the latest 365-day window; 142 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-05-27Stuka PaulPurchase (P)Common Stock20,000USD 0.88USD 17,600SEC filing ↗
2026-05-19Gleason Shane ThomasSale (S)Common Stock22,778USD 1.01USD 23,006SEC filing ↗
2026-05-14Stuka PaulPurchase (P)Common Stock5,000USD 1.15USD 5,750SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-05-27Stuka PaulPurchase (P)Common Stock20,000USD 0.88USD 17,600SEC filing ↗
2026-05-19Gleason Shane ThomasSale (S)Common Stock22,778USD 1.01USD 23,006SEC filing ↗
2026-05-14Stuka PaulPurchase (P)Common Stock5,000USD 1.15USD 5,750SEC filing ↗
2026-05-13Stuka PaulPurchase (P)Common Stock10,000USD 1.16USD 11,600SEC filing ↗
2026-05-12Slosman MarvinPurchase (P)Common Stock21,000USD 1.20USD 25,200SEC filing ↗
2026-05-11Stuka PaulPurchase (P)Common Stock10,000USD 1.19USD 11,900SEC filing ↗
2026-05-11Stuka PaulPurchase (P)Common Stock10,000USD 1.19USD 11,900SEC filing ↗
2026-05-08Stuka PaulPurchase (P)Common Stock65,626USD 1.16USD 76,126SEC filing ↗
2026-05-08Stuka PaulPurchase (P)Common Stock65,626USD 1.16USD 76,126SEC filing ↗
2026-05-07Ward Scott R.Purchase (P)Common Stock73,255USD 1.15USD 84,243SEC filing ↗
2026-05-07Stuka PaulPurchase (P)Common Stock6,378USD 1.15USD 7,335SEC filing ↗
2026-05-07ROUBIN GARY SPurchase (P)Common Stock90,000USD 1.18USD 106,200SEC filing ↗
2026-05-06Ward Scott R.Purchase (P)Common Stock15,995USD 1.15USD 18,394SEC filing ↗
2026-05-06Stuka PaulPurchase (P)Common Stock1,517USD 1.12USD 1,699SEC filing ↗
2026-02-02Gleason Shane ThomasSale (S)Common Stock2,000USD 1.60USD 3,200SEC filing ↗
2026-01-30Gleason Shane ThomasSale (S)Common Stock2,900USD 1.63USD 4,727SEC filing ↗
2026-01-29Gleason Shane ThomasSale (S)Common Stock5,000USD 1.65USD 8,250SEC filing ↗
2026-01-28Gleason Shane ThomasSale (S)Common Stock12,395USD 1.65USD 20,452SEC filing ↗
2026-01-27Gleason Shane ThomasSale (S)Common Stock4,781USD 1.66USD 7,936SEC filing ↗
2026-01-22Gleason Shane ThomasSale (S)Common Stock8,411USD 1.57USD 13,205SEC filing ↗
2026-01-21Gleason Shane ThomasSale (S)Common Stock17,593USD 1.62USD 28,501SEC filing ↗
2026-01-20Gleason Shane ThomasSale (S)Common Stock2,955USD 1.59USD 4,698SEC filing ↗
2026-01-16Gleason Shane ThomasSale (S)Common Stock2,250USD 1.61USD 3,622SEC filing ↗
2026-01-15Gleason Shane ThomasSale (S)Common Stock2,909USD 1.58USD 4,596SEC filing ↗
2026-01-14Ward Scott R.Award / grant (A)Common Stock88,053USD 0.00USD 0SEC filing ↗
2026-01-14Tommasoli AndreaAward / grant (A)Common Stock226,695USD 0.00USD 0SEC filing ↗
2026-01-14Stuka PaulAward / grant (A)Common Stock132,076USD 0.00USD 0SEC filing ↗
2026-01-14Slosman MarvinAward / grant (A)Restricted Stock Units1,114,792USD 0.00USD 0SEC filing ↗
2026-01-14ROUBIN GARY SAward / grant (A)Common Stock88,053USD 0.00USD 0SEC filing ↗
2026-01-14Lawless Michael AAward / grant (A)Common Stock226,695USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerNSPR
CIK0001433607
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
ExchangeNasdaq

Data coverage

Local Form 4 history142 transaction lines from 2020-01-02 to 2026-05-27
46 P purchase lines · 11 S sale lines · 85 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.